Atlas FDA

COLLEGE OF AMER PATH. REFER. PREP. FOR FIBRINOGEN

FDA 510(k) clearance K900377 · decided 1990-03-06

Clearance details

K-number
K900377
Device name
COLLEGE OF AMER PATH. REFER. PREP. FOR FIBRINOGEN
Applicant
Baxter Healthcare Corp
Decision
Substantially Equivalent
Date received
1990-01-26
Decision date
1990-03-06
Days to decision
39 days
Clearance type
Traditional
Product code
JPA
Device class
2
Regulation number
864.5425
Medical specialty
Hematology
Advisory committee
Hematology
Location
Miami, FL, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Baxter Healthcare Corp

The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
STA Satellite Max® (K253658)Diagnostica Stago, Inc.2026-04-27
Automated Blood Coagulation Analyzer CN-Series (CN-6000) (K250965)Sysmex America, Inc.2025-06-02
TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge (K251024)Haemonetics2025-04-30
TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge (K243858)Haemonetics Corporation2025-01-15
Citrated: K, KH, RTH, FFH (K232018)Haemonetics Corporation2024-03-29
ACL TOP 970 CL (K233790)Instrumentation Laboratory2023-12-29
ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgM (K221359)Instrumentation Laboratory CO2023-09-29
STA R Max 3, STA Compact Max 3 (K212183)Diagnostica Stago S.A.S2023-06-07
ROTEM sigma Thromboelastometry System (K201440)Tem Innovations GmbH2022-07-08
GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), GEM Hemochron 100 Low Range Activated Clotting Time Test (ACT-LR), directCHECK ACT+ Whole Blood Control, Level 1 and Level 2, directCHECK ACT-LR Whole Blood Control, Level 1 and Level 2 (K202101)Accriva Diagnostics, Inc.2021-12-29
Hemochron Signature Elite (K193041)Accriva Diagnostics, Inc.2019-11-22
QNext and DG-PT (K183390)Diagnostic Grifols, S.A.2019-08-21

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
Floseal Hemostatic Matrix, Floseal with Recothrom; Floseal Hemostatic Matrix, Floseal Fast Prep; 3 Floseal Hemostatic Ma (P990009/S077)Baxter Healthcare Corp2025-11-13
FLOSEAL MATRIX/FLOSEAL MATRIX HEMOSTATIC SEALANT/PROCEED HEMOSTATIC SEALANT (P990009/S076)Baxter Healthcare Corp2025-06-30
Floseal Hemostatic Matrix (P990009/S075)Baxter Healthcare Corp2025-01-30
Adept Adhesion Reduction Solution (P050011/S009)Baxter Healthcare Corp2024-08-23
Floseal Hemostatic Matrix, Floseal with Recothrom, Floseal Hemostatic Matrix, Floseal Fast Prep (P990009/S074)Baxter Healthcare Corp2024-08-15
Floseal Hemostatic Matrix (P990009/S073)Baxter Healthcare Corp2024-01-10
Floseal Hemostatic Matrix, Fast Prep, Floseal Hemostatic Matrix, RTS (P990009/S072)Baxter Healthcare Corp2023-12-12
Floseal Hemostatic Matrix, RT5 (P990009/S070)Baxter Healthcare Corp2023-02-02